SUVEN LIFE SCIENCES
Back to Cashflow Statement
|
SUVEN LIFE SCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-0.76 Cr | ₹-1.05 Cr | ₹396 Cr | ₹146 Cr | ₹35 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUVEN LIFE SCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-0.76 Cr |
| Mar2024 | ₹-1.05 Cr |
| Mar2023 | ₹396 Cr |
| Mar2022 | ₹146 Cr |
| Mar2021 | ₹35 Cr |
How is Cash Flow from Financing Activities of SUVEN LIFE SCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.76 Cr | Negative | |
| Mar2024 | ₹-1.05 Cr | Negative | |
| Mar2023 | ₹396 Cr | 171.49 | |
| Mar2022 | ₹146 Cr | 317.98 | |
| Mar2021 | ₹35 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹6,675.6 Cr | -3.3% | 10.1% | 35.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | -3.3% |
10.1% |
35.1% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses